Prenatal Exposure of Cypermethrin Induces Similar Alterations in Xenobiotic-Metabolizing Cytochrome P450s and Rate-Limiting Enzymes of Neurotransmitter Synthesis in Brain Regions of Rat Offsprings During Postnatal Development

[1]  R. Sethumadhavan,et al.  Effect of Gestational Exposure of Cypermethrin on Postnatal Development of Brain Cytochrome P450 2D1 and 3A1 and Neurotransmitter Receptors , 2015, Molecular Neurobiology.

[2]  S. Sultana,et al.  Early life arsenic exposure and brain dopaminergic alterations in rats , 2014, International Journal of Developmental Neuroscience.

[3]  Y. Yanagawa,et al.  Selective loss of parvalbumin-positive GABAergic interneurons in the cerebral cortex of maternally stressed Gad1-heterozygous mouse offspring , 2014, Translational Psychiatry.

[4]  K. Gupta,et al.  Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer's disease model via canonical Wnt/β-catenin pathway. , 2014, ACS nano.

[5]  R. Sethumadhavan,et al.  Imprinting of Cerebral and Hepatic Cytochrome P450s in Rat Offsprings Exposed Prenatally to Low Doses of Cypermethrin , 2013, Molecular Neurobiology.

[6]  E. Bromek,et al.  The catalytic competence of cytochrome P450 in the synthesis of serotonin from 5-methoxytryptamine in the brain: an in vitro study. , 2013, Pharmacological research.

[7]  M. Lang,et al.  Stress is a critical player in CYP3A, CYP2C, and CYP2D regulation: role of adrenergic receptor signaling pathways. , 2012, American journal of physiology. Endocrinology and metabolism.

[8]  S. Bandyopadhyay,et al.  Low density solvent based dispersive liquid-liquid microextraction with gas chromatography-electron capture detection for the determination of cypermethrin in tissues and blood of cypermethrin treated rats. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[9]  E. Bromek,et al.  Cytochrome P450 mediates dopamine formation in the brain in vivo , 2011, Journal of neurochemistry.

[10]  Jin-Sung Choi,et al.  Evidence for a separate mechanism of toxicity for the Type I and the Type II pyrethroid insecticides. , 2009, Neurotoxicology.

[11]  M. Ishihara-Sugano,et al.  Effect of dioxins on regulation of tyrosine hydroxylase gene expression by aryl hydrocarbon receptor: a neurotoxicology study , 2009, Environmental health : a global access science source.

[12]  M. DeVito,et al.  In Vitro Metabolism of Pyrethroid Pesticides by Rat and Human Hepatic Microsomes and Cytochrome P450 Isoforms , 2009, Drug Metabolism and Disposition.

[13]  J. Blusztajn,et al.  Nerve growth factor regulates the expression of the cholinergic locus and the high‐affinity choline transporter via the Akt/PKB signaling pathway , 2008, Journal of neurochemistry.

[14]  M. Mula Anticonvulsants - antidepressants pharmacokinetic drug interactions: the role of the CYP450 system in psychopharmacology. , 2008, Current drug metabolism.

[15]  W. Daniel,et al.  Regulation of liver cytochrome P450 by activation of brain dopaminergic system: physiological and pharmacological implications. , 2008, Biochemical pharmacology.

[16]  J. Hiney,et al.  The Pyrethroid Pesticide Esfenvalerate Suppresses the Afternoon Rise of Luteinizing Hormone and Delays Puberty in Female Rats , 2008, Environmental health perspectives.

[17]  D. Andersson,et al.  Cytochrome P450 2E1 in the substantia nigra: Relevance for dopaminergic neurotransmission and free radical production , 2008, Synapse.

[18]  A. Dhawan,et al.  Long lasting effects of prenatal exposure to deltamethrin on cerebral and hepatic cytochrome P450s and behavioral activity in rat offspring. , 2006, European journal of pharmacology.

[19]  Charlotte A. Ashby,et al.  CYTOCHROME P450 GENE INDUCTION IN RATS EX VIVO ASSESSED BY QUANTITATIVE REAL-TIME REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION (TAQMAN) , 2006, Drug Metabolism and Disposition.

[20]  T. Shors,et al.  Growth hormone is produced within the hippocampus where it responds to age, sex, and stress. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[21]  T. Sakuma,et al.  Modified expression of cytochrome P450 mRNAs by growth hormone in mouse liver. , 2006, Toxicology.

[22]  Alvaro Puga,et al.  Ah receptor signals cross-talk with multiple developmental pathways. , 2005, Biochemical pharmacology.

[23]  B. Lerer,et al.  Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism , 2005, The Pharmacogenomics Journal.

[24]  A. Anderson,et al.  GABA(A)/central benzodiazepine receptor and peripheral benzodiazepine receptor ligands as inducers of phenobarbital-inducible CYP2B and CYP3A. , 2004, Biochemical pharmacology.

[25]  P. Seth,et al.  Evidence for O-dealkylation of 7-pentoxyresorufin by cytochrome P450 2B1/2B2 isoenzymes in brain , 1998, Molecular and Cellular Biochemistry.

[26]  L D Burgoon,et al.  Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences. , 2004, Nucleic acids research.

[27]  C. Carpenter,et al.  Evidence that GABAergic neurons in the preoptic area of the rat brain are targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin during development. , 2002, Environmental health perspectives.

[28]  M. Luskin,et al.  Neural progenitor cells of the neonatal rat anterior subventricular zone express functional GABA(A) receptors. , 2002, Journal of neurobiology.

[29]  K. Wallace,et al.  Mechanisms of pyrethroid neurotoxicity: implications for cumulative risk assessment. , 2002, Toxicology.

[30]  J. Gustafsson,et al.  Cytochrome P450 in the brain; a review. , 2001, Current drug metabolism.

[31]  C. Thompson,et al.  Cytochromes P450 in brain: function and significance. , 2001, Current drug metabolism.

[32]  T. Sueyoshi,et al.  Nuclear receptor CAR as a regulatory factor for the sexually dimorphic induction of CYB2B1 gene by phenobarbital in rat livers. , 2001, Molecular pharmacology.

[33]  R. Strong,et al.  Identification of a glucocorticoid‐responsive element in the promoter region of the mouse tyrosine hydroxylase gene , 2001, Journal of neurochemistry.

[34]  N. Barden,et al.  Regulation of corticosteroid receptor gene expression in depression and antidepressant action. , 1999, Journal of psychiatry & neuroscience : JPN.

[35]  C. Marsden,et al.  Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylase , 1998, Neuroscience.

[36]  A. Jouvet,et al.  Tryptophan hydroxylase mRNAs analysis by RT‐PCR: Preliminary report on the effect of noradrenaline in the neonatal rat pineal gland , 1997, Journal of neuroscience research.

[37]  J. Blusztajn,et al.  Modulation of cholinergic locus expression by glucocorticoids and retinoic acid is cell‐type specific , 1997, FEBS letters.

[38]  A. Anadón,et al.  Toxicokinetics of deltamethrin and its 4'-HO-metabolite in the rat. , 1996, Toxicology and applied pharmacology.

[39]  B. Shapiro,et al.  Neonatal phenobarbital-induced persistent alterations in plasma testosterone profiles and testicular function. , 1996, Toxicology and applied pharmacology.

[40]  A. Parkinson An Overview of Current Cytochrome P450 Technology for Assessing the Safety and Efficacy of New Materials , 1996, Toxicologic pathology.

[41]  J. Mason,et al.  A Novel Cytochrome P450 Expressed Primarily in Brain (*) , 1995, The Journal of Biological Chemistry.

[42]  K. J. Jagannatha Rao,et al.  Modulation in Acetylcholinesterase of Rat Brain by Pyrethroids In Vivo and an In Vitro Kinetic Study , 1995, Journal of neurochemistry.

[43]  M. Waters,et al.  Immunohistochemical localization of growth hormone receptor binding protein in the mammalian cerebellum. , 1994, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[44]  P. Seth,et al.  Effect of deltamethrin on regional brain polyamines and behaviour in young rats. , 1994, Pharmacology & toxicology.

[45]  R. Tyndale,et al.  The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins. , 1990, Archives of biochemistry and biophysics.

[46]  M. Sonnier,et al.  Effects on rats of subacute intoxication with deltamethrin via an osmotic pump. , 1989, Drug and chemical toxicology.

[47]  L. Reiter,et al.  The effects of type I and II pyrethroids on motor activity and the acoustic startle response in the rat. , 1988, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[48]  C. Diéguez,et al.  GROWTH HORMONE NEUROREGULATION AND ITS ALTERATIONS IN DISEASE STATES , 1988, Clinical endocrinology.

[49]  C. Diéguez,et al.  GROWTH HORMONE NEUROREGULATION AND ITS ALTERATIONS IN DISEASE STATES , 1988 .

[50]  J. Jansson,et al.  Differential effects of neonatal and adult androgen exposure on the growth hormone secretory pattern in male rats. , 1987, Endocrinology.

[51]  J. Casida,et al.  Metabolism of the cis- and trans-isomers of cypermethrin in mice , 1981 .

[52]  L. Iversen,et al.  REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐I , 1966, Journal of neurochemistry.

[53]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.